Eversept Partners, LP Laboratory Corp Of America Holdings Transaction History

Eversept Partners, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2023	BUY	$204.81 - $262.19 $384,837 - $492,655	1,879 Added 35.1%	7,233 $1.48 Million
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $384,837 - $492,655	1,879 Added 35.1%	7,233 $1.48 Million
Q2 2022 Nov 08, 2023	SELL	$213.86 - $277.87 $6.96 Million - $9.05 Million	-32,556 Reduced 85.88%	5,354 $1.25 Million
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $6.96 Million - $9.05 Million	-32,556 Reduced 85.88%	5,354 $1.26 Million
Q1 2022 Nov 08, 2023	BUY	$259.82 - $298.18 $9.85 Million - $11.3 Million	37,910 New	37,910 $10 Million
Q1 2022 May 16, 2022	SELL	$259.82 - $298.18 $1.98 Million - $2.27 Million	-7,612 Reduced 16.72%	37,910 $10 Million
Q4 2021 Nov 08, 2023	SELL	$271.6 - $314.21 $22.5 Million - $26 Million	-82,789 Reduced 64.52%	45,522 $14.3 Million
Q4 2021 Feb 14, 2022	SELL	$271.6 - $314.21 $22.5 Million - $26 Million	-82,789 Reduced 64.52%	45,522 $14.3 Million
Q3 2021 Nov 08, 2023	BUY	$274.82 - $308.34 $35.3 Million - $39.6 Million	128,311 New	128,311 $36.1 Million
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $35.3 Million - $39.6 Million	128,311 New	128,311 $36.1 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.